Cerevel Therapeutics Holdings, Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
CERE on Nasdaq
Industry
Pharmaceutical Preparations
Location
222 Jacobs Street, Suite 200, Cambridge, Massachusetts

Insiders trading volume in the past year

Cerevel Therapeutics Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bain Capital Investors Llc 10%+ Owner $2.77 B +$125 M +4.72% Oct 16, 2023
Christopher R. Gordon Director, 10%+ Owner $2.67 B +$125 M +4.92% Jun 5, 2024
Adam Koppel Director, 10%+ Owner $2.67 B +$125 M +4.92% Jun 5, 2024
Ronald C. Renaud JR President & CEO, Director $22.3 M +$2.01 M +9.89% Jan 19, 2024
Marijn E. Dekkers Director $18.1 M Jun 5, 2024
Paul D. Burgess Title: Chief Business Development and Strategic Operations Officer $5.36 M +$502 K +10.3% Jan 19, 2024
Ramiro Sanchez Chief Medical Officer $4.32 M -$1.57 M -26.7% Jan 19, 2024
Susan ALTSCHULLER Chief Financial Officer $4.14 M -$572 K -12.1% Jan 19, 2024
Kenneth DiPietro Chief Human Resources Officer $3.74 M -$591 K -13.6% Jan 19, 2024
N. Anthony Coles Director $3.02 M -$20.1 M -86.9% Jul 1, 2024
Kathleen Tregoning Title: Chief Corporate Affairs Officer $2.95 M -$260 K -8.11% Jan 19, 2024
Scott Akamine Chief Legal Officer $2.8 M -$969 K -25.7% Jan 19, 2024
Gabrielle Sulzberger Director $2.39 M Jun 5, 2024
Norbert G. Riedel Director $2.3 M Jun 5, 2024
Mark Bodenrader Title: Senior Vice President, Finance and Chief Accounting Officer $1.8 M -$327 K -15.4% Jan 19, 2024
Abraham Ceesay President $1.23 M Feb 6, 2023
John Renger Chief Scientific Officer $890 K -$89.8 K -9.16% Feb 6, 2024
Ruth Mckernan Director $558 K Jun 5, 2024
Douglas E. Giordano Director $558 K Jun 5, 2024
Patrick Deval L Director $558 K -$753 K -57.4% Jun 5, 2024
Perceptive Advisors Llc Director $0 +$20 M Feb 20, 2024
PF Equity Holdings 1 B.V. 10%+ Owner Mar 31, 2022
Suneet Varma Director Jun 14, 2022

Recent Insider Transactions by Companies or Individuals for Cerevel Therapeutics Holdings, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership